Indian Journal of Critical Care Case Report

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  4 (2025)
Volume  3 (2024)
Volume  2 (2023)
Volume  1 (2022)
Related articles

VOLUME 2 , ISSUE 3 ( May-June, 2023 ) > List of Articles

CASE REPORT

Phenytoin Overdose-induced Rhabdomyolysis: A Rare Case Report

Neeraja Vijayan, Nakka Vihari, Mohd Nadeem, Naresh K Midha, Varatharajan Sakthivadivel, MK Garg

Keywords : Acute kidney injury, Phenytoin, Rhabdomyolysis

Citation Information : Vijayan N, Vihari N, Nadeem M, Midha NK, Sakthivadivel V, Garg M. Phenytoin Overdose-induced Rhabdomyolysis: A Rare Case Report. 2023; 2 (3):69-71.

DOI: 10.5005/jp-journals-11006-0054

License: CC BY-NC 4.0

Published Online: 26-06-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Introduction: Phenytoin is the commonly used antiepileptic medication for abortive as well as maintenance therapy. Even though phenytoin is associated with various side effects, only a few cases of phenytoin-induced rhabdomyolysis have been reported so far. Most cases are either due to parenteral use for status epilepticus or hypersensitivity reaction to maintenance therapy. Case description: We present an 18-year-old male, on regular treatment for a seizure disorder, who presented with altered sensorium following ingestion of 15–20 tablets of phenytoin (1500–2000 mg) and was found to have acute kidney injury (AKI) due to rhabdomyolysis secondary to phenytoin toxicity. The patient recovered completely with hemodialysis and supportive care. Conclusion: Phenytoin overdose-induced rhabdomyolysis is a rare occurrence with high risk of acute kidney injury. Awareness of clinicians about this rare complication is helpful for early diagnosis and treatment.

HTML PDF Share
  1. Michael JR, Mitch WE. Reversible renal failure and myositis caused by phenytoin hypersensitivity. JAMA 1976;236(24):2773–2775. DOI: 10.1001/jama.1976.03270250041024
  2. Warren JD, Blumbergs PC, Thompson PD. Rhabdomyolysis: a review. Muscle Nerve 2002;25(3):332–347. DOI: 10.1002/mus.10053
  3. Soriano VV, Tesoro EP, Kane SP. Characterization of free phenytoin concentrations in end-stage renal disease using the Winter-Tozer equation. Ann Pharmacother 2017;51(8):669–674. DOI: 10.1177/1060028017707541
  4. Olaniran K, Keshishyan S, Assallum H. Phenytoin-induced rhabdomyolysis. J Case Rep Med 2015;4:1–3. DOI: 10.4303/jcrm/235849
  5. Curry SC, Chang D, Connor D. Drug- and toxin-induced rhabdomyolysis. Ann Emerg Med 1989;18(10):1068–1084. DOI: 10.1016/s0196-0644(89)80933-3
  6. Engel JN, Mellul VG, Goodman DB. Phenytoin hypersensitivity: a case of severe acute rhabdomyolysis. Am J Med 1986;81(5):928–930. DOI: 10.1016/0002-9343(86)90371-2
  7. Kim H, Jo S, Park KW, et al. A case of phenytoin-induced rhabdomyolysis in status epilepticus. J Epilepsy Res 2016;6(1):36–38. DOI: 10.14581/jer.16007
  8. Zwaenepoel B, Le Roy S, Decruyenaere A, et al. Letter to the editor: phenytoin-induced rhabdomyolysis. Acta Neurol Belg 2019;119(2):293–294. DOI: 10.1007/s13760-018-1032-7
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.